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after preliminary refinement. The final atomic model of Most strikingly, the XIAP-BIR3 domain forms a hetero- pase-9. On the other side, the N terminus of the small subunit of caspase-9 reaches out to interact with a conserved surface groove on XIAP-BIR3 ( Figures 1A and 1B ). caspase-9 was found to interact with the BIR3 domain of XIAP (Srinivasula et al., 2001 ). Despite these advances, it XIAP-BIR3 Traps Caspase-9 in was largely unclear how XIAP-mediated inhibition of an Inactive Conformation caspase-9 actually occurs.
Previous structural studies on the dimeric caspase-9 In this paper, we report the crystal structure of casrevealed that the active site in one monomer exists in pase-9 in an inhibitory complex with the BIR3 domain of a productive conformation while the other active site is XIAP, which reveals a surprising mechanism of caspase unraveled in the adjacent monomer (Renatus et al., 2001) inhibition. Through binding, the XIAP-BIR3 domain traps ( Figure 1C) . Interestingly, the structure of the BIR3-caspase-9 in a monomeric state and deprives it of any bound caspase-9 in the inhibitory complex is very similar possibility of catalytic activity. We provide several lines to that of the inactive half of the caspase-9 dimer (Figure of additional biochemical evidence to illustrate the 1D), with a root-mean-square deviation (rmsd) of 0.97 Å mechanisms of caspase-9 inhibition and regulation.
for all 221 C␣ atoms. In particular, the active site loops of the BIR3-bound caspase-9 closely resemble those of the inactive half of the caspase-9 dimer ( Figure 1D ).
Results
To examine this scenario in detail, we compared the four active site loops from the BIR3-bound caspase-9 Crystallization and Structure Determination The BIR3 domain of XIAP readily forms a tight complex with those from the active half as well as the inactive half of the caspase-9 homodimer ( Figure 2A ). All 48 C␣ with caspase-9 and inhibits its catalytic activity with a potency similar to that of the intact full-length XIAP (Sun atoms of the active site loops can be superimposed with an rmsd of 1.3 Å between the BIR3-bound caspase-9 et al., 2000 and data not shown). To reveal the mechanism of XIAP-mediated inhibition of caspase-9, we and the inactive half of caspase-9. For these two cases, the L1, L2, and L3 loops exhibit nearly identical conforsought to determine the crystal structure of a caspase-9/ XIAP-BIR3 complex. After numerous trials, we were able mations whereas the L4 loops are in the same general location (Figures 2A, 2B , and 2D). In this inactive conforto generate crystals of the catalytic domain of caspase-9 (residues 139-416) in an inhibitory complex with mation, the substrate binding groove is partially occupied by the L3 loop itself. In sharp contrast, there is a the XIAP-BIR3 domain (residues 252-350). The crystals are in the spacegroup P6 5 22 and diffract X-rays beyond large difference between the active site conformations of the BIR3-bound caspase-9 and the active half of the 2.4 Å resolution (Table 1 ). The caspase-9 moiety in the asymmetric unit was located by molecular replacement caspase-9 homodimer (Figures 2A, 2B , and 2C), resulting in 5.7 Å rmsd for the same 48 aligned C␣ atoms. using the atomic coordinates of the active half of the caspase-9 dimer as the initial search model (PDB code Thus, the XIAP-BIR3 domain not only sequesters caspase-9 in a monomeric state but also traps the active 1JXQ) (Renatus et al., 2001 ). The electron density for the bound BIR3 domain became immediately apparent site loops in their unproductive conformations. Recognition of Caspase-9 by XIAP-BIR3 caspase-9 and the backbone carbonyl group of Trp323. Interestingly, Leu244, Gln245, and Pro247 all reside in Recognition of caspase-9 by the XIAP-BIR3 domain involves a large protein-protein interface as well as a prea protruding loop that is unique to caspase-9 (Earnshaw et al., 1999). This characteristic loop, with a previously dicted interaction between the N terminus of the caspase-9 small subunit and a highly conserved surface undefined function, is found to play an important role in binding to the BIR3 domain of XIAP. groove on BIR3 (Srinivasula et al., 2001 ). This recognition is dominated by a large collection of van der Waals
In the center of the protein-protein interface, Leu344 and His343 from BIR3 anchor the recognition of cascontacts and further supported by 11 intermolecular hydrogen bonds at the interface (Figure 3) . pase-9 ( Figure 3C ). Leu344 makes multiple van der Waals interactions to a hydrophobic pocket formed by At the periphery of the protein-protein interface, two nonpolar residues (Pro325 and Gly326) between helices four residues (Leu384, Leu385, Ala388, and Cys403) of caspase-9. His343 accepts an intermolecular hydrogen ␣3 and ␣4 of BIR3 closely stack against a hydrophobic surface formed by Leu244, Pro247, Phe404, and Phe406 bond from a caspase-9 backbone amide group while simultaneously making van der Waals contacts to Cys of caspase-9 ( Figure 3B ). These interactions are supported by a specific hydrogen bond between Gln245 of 403, Phe404, and Phe496 of caspase-9 ( Figure 3C ). 
Mutational Analysis
To corroborate our structural observation, we devised cient for the binding to XIAP-BIR3, and mutation of this sequence abolished BIR3-mediated inhibition of casa caspase-9 assay using its physiological substrate, procaspase-3 zymogen, and investigated the ability of pase-9 due to the loss of binding (Srinivasula et al., 2001 ). This tetrapeptide was predicted to bind to the various XIAP-BIR3 point mutants to inhibit caspase-9. A mutation on the catalytic residue, Cys163 to Ala, was conserved surface groove of BIR3 in the same manner as the N terminus of the mature Smac protein (Srinivaintroduced in the substrate procaspase-3 to prevent its self-activation or cleavage. As anticipated, the wild-type sula et al., 2001 ). Indeed, this interaction is just as predicted, with Ala316 playing the anchoring role in this (WT) caspase-9 cleaved the procaspase-3 precursor into p17 and p12 fragments ( Figure 3E , lane 1), and part of the interface ( Figure 3D ). Interestingly, this IAP binding motif does not just bind to the BIR3 domain in incubation with the WT BIR3 protein (residues 252-350) resulted in the efficient inhibition of this activity (lane 2). isolation; it also packs against two adjacent caspase-9 residues, Pro336 and Pro338, through van der Waals
In contrast to the WT protein, mutation of any of the four critical residues of BIR3 (P325G, G326E, H343A, contacts ( Figure 3D ). These interactions mold the caspase-9 peptide-BIR3 binding into the larger and continuand L344A) led to loss of this inhibition as judged by the cleavage of procaspase-3 precursor ( Figure 3E , lanes 4, ous protein-protein recognition interface ( Figure 3A ).
Pro336 and its adjacent residues of caspase-9 consti-5, 8, and 9). The result that H343A can no longer inhibit caspase-9 confirms an earlier report (Sun et al., 2000). tute the core element of the L2Ј loop in stabilizing the productive conformation of the active site loops in the These residues make important contributions to the recognition and sequestration of the caspase-9 monomer structure of the caspase-9 homodimer (Renatus et al., 2001 ). However, in the inhibitory caspase-9/BIR3 com-( Figures 3B-3D) ; mutation of any of these residues presumably destabilizes the interface, allowing the formaplex, this region is involved in stabilizing the interactions between the IAP binding motif of caspase-9 and the tion of the caspase-9 homodimer and subsequent restoration of catalytic activity. It is of particular note that BIR3 domain. This analysis further reinforces the notion that XIAP-BIR3 not just sequesters caspase-9 in its none of these mutations affects the conserved surface Using a coexpression strategy, we generated three caspase-9 variants ( Figure 4A ), each of which contains an invariant large subunit (residues 139-315) and a distinct small subunit. Thus, these caspase-9 variants represent their "cleaved" or "active" form. The only difference is that, relative to the WT caspase-9, the ⌬S and ⌬L variants contain deletion of residues 316-330 and 316-338, respectively ( Figure 4A) . Removal of the fragment 316-330 does not affect any residue implicated in the stabilization of the active site conformation and hence should not have any negative impact on the catalytic activity of caspase-9. However, since the removal of residues 331-338 eliminates the formation of the loop-bundle, caspase-9 (⌬L) was expected to be inactive.
In our in vitro caspase-9 assays, equal amounts of the caspase-9 variants were incubated with the procaspase-3 (C163A) substrate; the cleavage efficiency was monitored by SDS-PAGE and Coomassie staining (Figure 4B) . In complete agreement with our structure-based prediction, caspase-9 (⌬L) did not exhibit a detectable level of catalytic activity compared to the WT protein.
In contrast, caspase-9 (⌬S) was approximately 2-fold more active than the WT protein ( Figure 4B ). This is likely due to the elimination of the 15 flexible residues (315-330), which may impede substrate entry into the active site during catalysis.
Our data demonstrate that the L2Ј loop plays an indis- In all our attempts, we have consistently observed a as well. This hypothesis predicts that monomeric caspase-9 must be catalytically inactive.
single species of caspase-9 in solution by gel filtration as well as by a variety of other criteria. To examine this hypothesis, we generated a monomeric caspase-9 by mutating Phe404, which resides To accurately determine the basal state of caspase-9 in solution, we examined the molecular weight of casin the center of the homodimerization interface, to a negatively charged residue Asp ( Figure 4A ). This mutapase-9 by sedimentation equilibrium analysis using analytical ultracentrifugation (Table 2) . Little, if any, variation tion is expected to eliminate homodimerization of caspase-9 as burying two charged residues in the center of in molecular weight as a function of rotor speed was observed for any of the caspase-9 samples, indicating a predominantly hydrophobic interface is energetically extremely unfavorable. Indeed, this mutant caspase-9 that the protein behaves mostly as a single species in solution (data not shown). Interestingly, both the pro-(F404D) exists exclusively as a monomer in solution (data not shown and see below). As anticipated, cascessed caspase-9 and the unprocessed procaspase-9 zymogen were found to have a molecular weight consispase-9 (F404D) did not exhibit any detectable enzymatic activity ( Figure 4B ), despite the presence of all sequence tent with that of a monomer. In addition, this analysis confirms that the XIAP-BIR3 domain forms a stable hetelements required to form an active site.
Next, we examined whether the L2Ј loop in caspase-9 erodimer with the caspase-9 monomer (Table 2 ). In contrast, we demonstrate that the active caspase-7, which plays the same essential role as in caspase-3 and -7. Molecular weight represents global analysis of data collected at four rotor speeds, 10 K, 15 K, 20 K, and 25 K rpm. All data were collected at 4ЊC. The caspase-9/XIAP-BIR3 sample contains the wild-type caspase-9 residues 139-315 and 316-416 and XIAP residues 252-350. The active caspase-9 contains residues 139-315 and 316-416, except that residues Glu304-Asp305-Glu306 have been replaced by three Ala residues to reduce limited proteolysis by the intrinsic enzymatic activity of caspase-9. The procaspase-9 zymogen contains residues 139-416. The active caspase-7 contains residues 51-198 and 200-303.
is known to be dimeric, indeed exhibits a molecular with a caspase-9 monomer through the same interface that is required for the homodimerization of caspase-9 weight consistent with that of a dimer (Table 2) .
If the processed caspase-9 is mostly a monomer in (Figure 5 ). Thus, XIAP traps caspase-9 in an inactive monomeric state, preventing any possibility of its homosolution, how can it exhibit any catalytic activity in isola- caspase-9 ( Figure 3D) . Thus, the caspase-9/BIR3 structure also shows, in a broad sense, how a protein inhibitor Discussion can mess up the active state of a protease by trapping half of it (the monomer) in an inactive state. This mecha-A mechanistic paradigm on the regulation of caspase-9 activation and inhibition has emerged from this study nism prevents the assembly of a functional protease. Caspase-9, one of the best-characterized initiator (Figure 5 ). At the basal state, both the procaspase-9 zymogen and the processed caspase-9 exist mostly as caspases, plays an important role in apoptosis and directly activates the effector caspases-3 and -7. Although a monomer. These monomers have the potential to be activated (by Apaf-1, for example) or inhibited (Figure XIAP potently inhibits the catalytic activity of both caspase-9 and caspase-3/-7, the underlining mechanisms 5). XIAP potently inhibits the catalytic activity of caspase-9 by using the BIR3 domain to heterodimerize are entirely different. In the case of the effector cas- could be to promote the dimerization of caspase-9. In the protease/inhibitor paradigm of inhibition by blocking this case, the puzzling question would be why the apothe active site. For caspase-9, however, only the inactive ptosome has a 7-fold symmetry. It should be noted that, monomer is trapped by the BIR3 domain of XIAP through even in this case, it remains possible that the apoan extensive protein-protein interface. Thus, complete ptosome activates caspase-9 using a different mechainhibition of enzymatic activity by XIAP is achieved withnism compared to the homodimerization of caspase-9, out even touching the active site of caspase-9.
yet the end result is the same. On the other hand, if The recognition interface between caspase-9 and the catalytic activity of the homodimerized caspase-9 is XIAP-BIR3 has two components. The binding between significantly less than that of the apoptosome-activated the IAP binding tetrapeptide of caspase-9 and the concaspase-9, then the concept of "dimerization drives the served surface groove on XIAP-BIR3 is necessary but activation of initiator caspases" certainly needs to be not sufficient for any XIAP-mediated inhibition. An addireevaluated. In any case, a definitive answer on this tional protein-protein interface must be present to direct issue awaits a detailed structural analysis. the inhibition specificity. This conclusion allows us to explain many published observations. For example, de- 
